Lung-Cancer Screening and the NELSON Trial. Reply

Affiliations

¹ Erasmus MC-University Medical Center Rotterdam, Rotterdam, the Netherlands h.dekoning@erasmusmc.nl.
² Institute for DiagNostic Accuracy, Groningen, the Netherlands.

Comment

Harry J de Koning et al. N Engl J Med. 2020.

. 2020 May 28;382(22):2165-2166.

doi: 10.1056/NEJMc2004224.

¹ Erasmus MC-University Medical Center Rotterdam, Rotterdam, the Netherlands h.dekoning@erasmusmc.nl.
² Institute for DiagNostic Accuracy, Groningen, the Netherlands.

No abstract available

Comment on

Lung-Cancer Screening and the NELSON Trial.
Lindholt JS, Søgaard R. Lindholt JS, et al. N Engl J Med. 2020 May 28;382(22):2164. doi: 10.1056/NEJMc2004224. N Engl J Med. 2020. PMID: 32459929 No abstract available.
Lung-Cancer Screening and the NELSON Trial.
Kennedy MP. Kennedy MP. N Engl J Med. 2020 May 28;382(22):2164-2165. doi: 10.1056/NEJMc2004224. N Engl J Med. 2020. PMID: 32459930 No abstract available.
Lung-Cancer Screening and the NELSON Trial.
Autier P. Autier P. N Engl J Med. 2020 May 28;382(22):2165. doi: 10.1056/NEJMc2004224. N Engl J Med. 2020. PMID: 32459931 No abstract available.